JP2008538756A - 塩基性窒素を有さない新規チアゾリジノン類、それらの生成及び医薬剤としての使用 - Google Patents
塩基性窒素を有さない新規チアゾリジノン類、それらの生成及び医薬剤としての使用 Download PDFInfo
- Publication number
- JP2008538756A JP2008538756A JP2008507025A JP2008507025A JP2008538756A JP 2008538756 A JP2008538756 A JP 2008538756A JP 2008507025 A JP2008507025 A JP 2008507025A JP 2008507025 A JP2008507025 A JP 2008507025A JP 2008538756 A JP2008538756 A JP 2008538756A
- Authority
- JP
- Japan
- Prior art keywords
- optionally
- alkyl
- heterocycloalkyl
- ring
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *N(C(CS1)=O)C1=C(C(O)=O)C#N Chemical compound *N(C(CS1)=O)C1=C(C(O)=O)C#N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005020105A DE102005020105A1 (de) | 2005-04-25 | 2005-04-25 | Neue Thiazolidinone ohne basischen Stickstoff, deren Herstellung und Verwendung als Arzneimittel |
PCT/EP2006/004226 WO2006114334A1 (en) | 2005-04-25 | 2006-04-24 | New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2008538756A true JP2008538756A (ja) | 2008-11-06 |
Family
ID=36693046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008507025A Pending JP2008538756A (ja) | 2005-04-25 | 2006-04-24 | 塩基性窒素を有さない新規チアゾリジノン類、それらの生成及び医薬剤としての使用 |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1874744A1 (de) |
JP (1) | JP2008538756A (de) |
KR (1) | KR20080005971A (de) |
CN (1) | CN101208317A (de) |
AU (1) | AU2006239444A1 (de) |
BR (1) | BRPI0610832A2 (de) |
CA (1) | CA2605760A1 (de) |
DE (1) | DE102005020105A1 (de) |
IL (1) | IL186747A0 (de) |
MX (1) | MX2007013306A (de) |
NO (1) | NO20076038L (de) |
RU (1) | RU2007143513A (de) |
WO (1) | WO2006114334A1 (de) |
ZA (1) | ZA200710147B (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014069434A1 (ja) * | 2012-10-30 | 2014-05-08 | カルナバイオサイエンス株式会社 | 新規チアゾリジノン誘導体 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6480629B1 (ja) * | 2018-08-07 | 2019-03-13 | キッコーマン株式会社 | グルコースデヒドロゲナーゼの組換え製造方法 |
CN113533723B (zh) * | 2021-07-28 | 2023-06-20 | 中国医科大学附属第一医院 | 一种被hiv和/或siv感染的细胞的标志物及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD147241A1 (de) * | 1979-11-21 | 1981-03-25 | Klaus Peseke | Verfahren zur herstellung von furanderivaten |
DD267492A1 (de) * | 1987-12-01 | 1989-05-03 | Univ Rostock | Verfahren zur herstellung von thiazolidinderivaten |
PL372890A1 (en) * | 2002-05-03 | 2005-08-08 | Schering Aktiengesellschaft | Thiazolidinones and the use thereof as polo-like kinase inhibitors |
US20040092561A1 (en) * | 2002-11-07 | 2004-05-13 | Thomas Ruckle | Azolidinone-vinyl fused -benzene derivatives |
-
2005
- 2005-04-25 DE DE102005020105A patent/DE102005020105A1/de not_active Ceased
-
2006
- 2006-04-24 EP EP06742815A patent/EP1874744A1/de not_active Withdrawn
- 2006-04-24 MX MX2007013306A patent/MX2007013306A/es not_active Application Discontinuation
- 2006-04-24 JP JP2008507025A patent/JP2008538756A/ja active Pending
- 2006-04-24 CA CA002605760A patent/CA2605760A1/en not_active Abandoned
- 2006-04-24 BR BRPI0610832-6A patent/BRPI0610832A2/pt not_active Application Discontinuation
- 2006-04-24 RU RU2007143513/04A patent/RU2007143513A/ru unknown
- 2006-04-24 WO PCT/EP2006/004226 patent/WO2006114334A1/en active Application Filing
- 2006-04-24 AU AU2006239444A patent/AU2006239444A1/en not_active Abandoned
- 2006-04-24 KR KR1020077027261A patent/KR20080005971A/ko not_active Application Discontinuation
- 2006-04-24 CN CNA2006800228878A patent/CN101208317A/zh active Pending
-
2007
- 2007-10-18 IL IL186747A patent/IL186747A0/en unknown
- 2007-11-23 NO NO20076038A patent/NO20076038L/no not_active Application Discontinuation
- 2007-11-26 ZA ZA200710147A patent/ZA200710147B/xx unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014069434A1 (ja) * | 2012-10-30 | 2014-05-08 | カルナバイオサイエンス株式会社 | 新規チアゾリジノン誘導体 |
Also Published As
Publication number | Publication date |
---|---|
CN101208317A (zh) | 2008-06-25 |
EP1874744A1 (de) | 2008-01-09 |
DE102005020105A1 (de) | 2006-10-26 |
AU2006239444A1 (en) | 2006-11-02 |
KR20080005971A (ko) | 2008-01-15 |
CA2605760A1 (en) | 2006-11-02 |
ZA200710147B (en) | 2009-08-26 |
MX2007013306A (es) | 2007-12-13 |
BRPI0610832A2 (pt) | 2010-07-27 |
RU2007143513A (ru) | 2009-06-10 |
NO20076038L (no) | 2008-01-16 |
WO2006114334A1 (en) | 2006-11-02 |
IL186747A0 (en) | 2008-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20040106451A (ko) | 폴로-유사 키나제 억제제로서의 티아졸리디논 및 그의 용도 | |
JP2004535414A (ja) | Cdk阻害性ピリミジン、それらの製造および薬剤としての使用 | |
CA2743756A1 (en) | Inhibitors of pim protein kinases, compositions, and methods for treating cancer | |
JP2005526765A (ja) | Cdk−阻害性2−ヘテロアリール−ピリミジン類、それらの生成及び医薬としての使用 | |
JP2005521631A (ja) | 細胞増殖を阻害するためのチアゾールベンズアミド誘導体及び医薬組成物、並びにそれらの使用法 | |
EP1567112A2 (de) | Neue chemischeverbindungen | |
JP2003522793A (ja) | 製薬におけるパウロン誘導体の使用 | |
JP2004532248A (ja) | キナーゼ阻害物質としての3,5−ジアミノ−1,2,4,−トリアゾール | |
CN107151250B (zh) | 嘧啶类七元环化合物、其制备方法、药用组合物及其应用 | |
TW202035412A (zh) | 雜芳基二氫嘧啶衍生物和治療b型肝炎感染之方法 | |
JP2008524139A (ja) | メタ置換チアゾリノン類、それらの製造及び医薬としての使用 | |
JP2008529985A (ja) | ポロ様キナーゼ(plk)のインヒビターとしてのチアゾリジノン類 | |
JP2023085300A (ja) | ヒストンデメチラーゼ阻害剤 | |
JP2007509892A (ja) | チアゾリジノン類、それらの生成及び医薬剤としての使用 | |
US6566363B2 (en) | Pyrazole-thiazole compounds, pharmaceutical compositions containing them | |
JP2008538755A (ja) | 塩基性窒素を有さない新規チアゾリジノン類、それらの生成及び医薬剤としての使用 | |
JP2008538756A (ja) | 塩基性窒素を有さない新規チアゾリジノン類、それらの生成及び医薬剤としての使用 | |
US20070010565A1 (en) | New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents | |
DE60110802T2 (de) | Heterozyklische-hydroximino-fluorene und ihre verwendung zur inhibierung von proteinkinasen | |
JP2009514984A (ja) | 新規化合物 | |
KR20070100830A (ko) | 폴로형 키나제 (plk)의 억제제로서 사용하기 위한티아졸리디논 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090213 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120522 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20121106 |